Quite a Ride! Meet the GCMI Team: Saylan Lukas, Director of Research and Development Engineering

So many engineers probably wanted to be an astronaut as kids at some point or another. Saylan Lukas wanted to design roller coasters.   Fortunately for GCMI, our clients and patients benefiting from novel medical technologies, Saylan’s elective in Biomedical Engineering taught by Dr. Sam Hulbert at Rose-Hulman Institute of Technology shifted his career course…

New Technologies for Neurosurgery, Urology and Endoscopy Earn Inaugural I3 GCMI Research Awards

“In partnership with Georgia CTSA (Clinical and Translational Science Alliance), the I3 (Imagine, Innovate, and Impact) GCMI Research Awards are intended to spark synergistic interactions among investigators from the Emory School of Medicine (SOM) with Georgia Tech affiliate the Global Center for Medical Innovation (GCMI). Proposals are envisioned to improve patient care by more effectively…

When Stars Align – Stridelink quickens its march to commercialization aligned with new remote monitoring capabilities and CMS CPT codes

Occasionally, even in the medtech innovation industry, stars align for a new technology to quickly, powerfully achieve commercialization and the associated clinical outcomes intended.   Such may well be the case for the team and technology at StrideLink.   As we reported last year, “StrideLink is a new technology venture, a first of its kind…

Early, consistent focus on the unmet need keeps Augment Health on a solid commercialization pathway

Stephen Kalinsky and Jared Meyers met on their first day as students in the Department of Biomedical Engineering at Georgia Tech. Five years later, the graduates have completed a 3-month tenure at ZeroTo510 in Memphis and are currently midstream in their endeavor to advance health and dignity for people dealing with spinal injuries or neurological…

The 2022 State of Medtech Design and Development Landscape

Medical technology innovation and critical supporting service providers are not only working through pent up demand for delayed projects from 2020 and 2021, but also striving to advance technologies that reduce cost and improve patient outcomes developed much more recently. The U.S. FDA is striving to support innovation with new programs and guidelines that improve…

Partner Event to Consider: Health Connect South’s 2022 Annual Gathering

Our colleagues at Health Connect South are in the final stages of preparing for their 2022 Gathering on September 22nd at the Georgia Aquarium.   “Though the Southeast is home to world-class health assets, there is surprisingly little interdisciplinary clarity around areas of focus, impact, needs and capacity within and among our health assets. We…

Are you a life science innovator seeking funding in the next 12 months? Applications are open for PitchRounds at AdvanSE 2022.

Our colleagues at Southeast Life Sciences are now accepting applications for Pitchrounds at AdvanSE 2022.   They’re seeking the southeast’s most promising life science innovators across multiple life science categories including biopharma, medtech, diagnostic, digital health and agriculture biotechnology technologies.   Along with Southeast Life Sciences, we encourage those seeking early rounds of six figures…

An Introduction to the U.S. FDA’s Investigational Device Exemption (IDE): A GCMI Webinar

Learn from our experience to streamline your regulatory pathway and set your new medical device or technology up for commercialization success.   Investigational Device Exemptions are required by the U.S. FDA for devices or technologies that require clinical use before regulatory approval or general market release. Examples of devices that may require an IDE study…

Under pressure: cadaveric testing yields initial human organ validation for GT Capstone Expo winners’ minimally invasive treatment for cardiac arrest

There are approximately 292,000 cases of in-hospital cardiac arrest every year for which the survival rate is less than 24 percent. Resuscitative efforts and supporting technologies are ineffective, slow, fatiguing, traumatic and expensive.   As their Fall 2020 Capstone Project, a group of students from the Georgia Tech Schools of Biomedical, Electrical and Mechanical Engineering…

News: Georgia Tech Names Raghupathy Sivakumar Inaugural Interim Chief Commercialization Officer

Last month, Georgia Tech named Raghupathy “Siva” Sivakumar inaugural Interim Chief Commercialization Officer. From Georgia Tech Research Horizons:   “Sivakumar will bring together commercialization and technology transfer activities from across campus with a goal of moving more intellectual property out into the marketplace to help expand Georgia Tech’s impact on the world. Attaining that goal…